chr5-9629732-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_019599.3(TAS2R1):c.301G>A(p.Val101Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,613,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019599.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R1 | ENST00000382492.4 | c.301G>A | p.Val101Ile | missense_variant | 1/1 | 6 | NM_019599.3 | ENSP00000371932.2 | ||
TAS2R1 | ENST00000514078.1 | c.181G>A | p.Val61Ile | missense_variant | 2/2 | 3 | ENSP00000476190.1 | |||
TAS2R1 | ENST00000506620.1 | c.181G>A | p.Val61Ile | missense_variant | 3/3 | 2 | ENSP00000475387.1 | |||
ENSG00000248525 | ENST00000504182.2 | n.36-6130G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000164 AC: 41AN: 250076Hom.: 0 AF XY: 0.000192 AC XY: 26AN XY: 135210
GnomAD4 exome AF: 0.000129 AC: 189AN: 1461680Hom.: 0 Cov.: 32 AF XY: 0.000147 AC XY: 107AN XY: 727118
GnomAD4 genome AF: 0.000151 AC: 23AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2024 | The c.301G>A (p.V101I) alteration is located in exon 1 (coding exon 1) of the TAS2R1 gene. This alteration results from a G to A substitution at nucleotide position 301, causing the valine (V) at amino acid position 101 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at